The stress response mobilizes the body's energy stores in order to respond to a threatening situation. A striking observation is the diversity of metabolic changes that can occur in response to stress. On one hand acute intense stress is commonly associated with feeding suppression and reduced body weight gain. The activation of the hypothalamic-pituitary-adrenal axis and the release of corticotropin-releasing hormone (CRH) might partially explain the anorexigenic effects of acute stress. CRH can also stimulate the sympathetic nervous system and catecholamine release, inducing hypophagia and weight loss, through their effects on the liver and on white and brown adipose tissue. On the other hand, chronic stress can lead to dietary over-consumption (especially palatable foods), increased visceral adiposity and weight gain. These obesogenic effects of stress are mainly explained by the chronic release of glucocorticoids and neuropeptide Y. Stressful situations can activate all of these systems together, and the metabolic outcome of stress exposure is determined by a host of intrinsic and external factors. If we are to find new ways to limit the development of stress-linked cardiometabolic diseases, we need to discover why, in some circumstances, the pro-obesogenic effects of stress outweigh its anorexigenic effects. The equilibrium between the different components of the stress response that accompany chronic stress situations could be crucial to understand and prevent the long-lasting adverse metabolic effects induced by stress. Relevance of the stress response and stress hormones for energy balance Stress is the response of an organism to factors actually or symbolically endangering its integrity. Irrespective of the type of stress, information about the situation converges on the paraventricular nucleus (PVN) of the hypothalamus, a brain region crucially involved in the stress response. The dorsal cap and submagnocellular part of the PVN send projections to the brainstem and spinal nuclei controlling sympathetic and parasympathetic activity. During stress, activation of the sympathetic nervous system (SNS) stimulates epinephrine and a smaller, although significant norepinephrine release from the adrenal medulla, as well as norepinephrine release from the sympathetic nerve endings [1] . These catecholamines stimulate a (1-2) and b (1-3) receptors expressed in different central and peripheral targets to coordinate cardiovascular responses (e.g. cardiac output and respiration are accelerated), redirect blood flow to arouse the brain and prepare the muscles and the heart for a 'fight or flight' response. The parvocellular part of the PVN is the origin of neurons sending axons to the median eminence, where they release corticotropin releasing hormone (CRH) thereby activating the hypothalamic-pituitary adrenal axis (HPA). CRH reaches the pituitary gland and stimulates the synthesis and release of adrenocorticotropic hormone (ACTH). Circulating ACTH acts on melanocortin 2 (MC-2) receptors in the zona fasciculata of the adrenal cortex, stimulating the synthesis and release of glucocorticoids (cortisol in humans and corticosterone in rodents). These act in several tissues through the mineralocorticoid and glucocorticoid receptors (MR and GR) and exert negative feedback on the HPA axis suppressing the stress response [2] .
Stress is the response of an organism to factors actually or symbolically endangering its integrity. Irrespective of the type of stress, information about the situation converges on the paraventricular nucleus (PVN) of the hypothalamus, a brain region crucially involved in the stress response. The dorsal cap and submagnocellular part of the PVN send projections to the brainstem and spinal nuclei controlling sympathetic and parasympathetic activity. During stress, activation of the sympathetic nervous system (SNS) stimulates epinephrine and a smaller, although significant norepinephrine release from the adrenal medulla, as well as norepinephrine release from the sympathetic nerve endings [1] . These catecholamines stimulate a (1) (2) and b (1) (2) (3) receptors expressed in different central and peripheral targets to coordinate cardiovascular responses (e.g. cardiac output and respiration are accelerated), redirect blood flow to arouse the brain and prepare the muscles and the heart for a 'fight or flight' response. The parvocellular part of the PVN is the origin of neurons sending axons to the median eminence, where they release corticotropin releasing hormone (CRH) thereby activating the hypothalamic-pituitary adrenal axis (HPA). CRH reaches the pituitary gland and stimulates the synthesis and release of adrenocorticotropic hormone (ACTH). Circulating ACTH acts on melanocortin 2 (MC-2) receptors in the zona fasciculata of the adrenal cortex, stimulating the synthesis and release of glucocorticoids (cortisol in humans and corticosterone in rodents). These act in several tissues through the mineralocorticoid and glucocorticoid receptors (MR and GR) and exert negative feedback on the HPA axis suppressing the stress response [2] .
Collectively all of the stress-linked changes in the SNS and HPA axes mobilize the body's energy stores in order to allow a rapid response that favors survival under acute threatening situations. However, modern life stressors are typically chronic, including financial worries, work problems, family responsibilities or health concerns [3] . In this context, the stress response is not beneficial but rather becomes harmful, predisposing individuals to visceral obesity and cardiometabolic disease [4, 5] , a leading cause of death worldwide. Still, the effects of stress on body weight and food intake are controversial. Although there is a ink between stress and changes in eating habits in both men and women [6] , not everyone gains weight under stress: about 40% increase and 40% decrease their food intake [7] . Many studies have contributed to understand the individual differences between those that gain and those that lose weight [6, [8] [9] [10] . However, other factors like the chronicity and intensity of the stressors, factors that are difficult to manipulate in humans, can be of major importance and could help to understand the physiological and neurobiological mechanisms underpinning the metabolic response to stress.
In this review we attempt to untangle the complex relationship between stress and food intake, which tends to favor an anorexigenic response when the stress is acute and severe. We adopt the view that under chronic or repeated stress, (neuro)physiological adaptations occur that give way to an orexigenic response. We describe some of the known mechanisms and signaling systems and highlight the important role of CRH, glucocorticoids and NPY. Given that a number of recent reviews describe the interaction between obesity and stress, we limit this review to specific, perhaps less understood aspects of this relationship that include the interactions between the anorexigenic and orexigenic effectors of the HPA and SNS axes during the stress response.
Severe stress induces anorexia
The most commonly reported result in rodents is that stress reduces food intake and body weight in a manner that is directly related to the stress severity [11] . A single exposure to restraint [12] or immobilization [13] induces a reduction in body weight that can persist >10 days, even if the food intake is quickly normalized [12, 13] . Moreover, these body weight-lowering effects can be extremely long lasting after repeated exposure to the stressor. Strikingly, rats do not catch up to the weight of non-stress controls even by 80 days after 3 consecutive days of restraint [14] . Thus, after stress, rats appear to have a capacity to defend a new lower set-point for energy homeostasis despite returning to normal caloric intake and so energy expenditure must also be adjusted. However, even although chronically stressed rats do not catch up to the weight of control never-stressed rats, preliminary observations from our group demonstrate that rats exposed to 1 h/day of forced swim lose weight only on the first days of stress exposure, but then start to gain weight afterwards. Interestingly, this chronic stress-linked weight gain occurs despite a reduction in food intake, suggesting that metabolic adaptations occur during stress which increase caloric efficiency. Supportively, Pastor-Ciurana et al. [15 ] demonstrated that prior chronic unpredictable or repeated stress experience protects rats from the anorectic effects of a subsequent acute and intense stressor like immobilization (Figure 1 ). Therefore, although intense stress seems to induce immediate body weight loss, compensatory mechanisms exist that restore energy balance.
Short-term anorexia: a role for CRH and Urocortins
The CRH system initiates the HPA axis response to stress and it has been extensively linked to stress-induced anorexia. CRH and its analogs Urocortins (UCN) 1-3 act as neurotransmitters and activate CRHR1 and CRHR2 receptors that have a role in food intake, weight gain and metabolic control [16 ,17] . Under basal conditions, peripheral and i.c.v. injections of CRH or Urocortins decrease food intake and body weight gain for up to 48 hours after injection, with Ucn1 having the most potent anorexigenic effects [18, 19] . Despite this, CRHR1 or CRHR2 knockout mice do not differ from wildtypes regarding their food intake and body weight under nonstressed conditions, suggesting that CRH receptors are not needed for the basal regulation of these parameters [20, 21] . However, severe impairments in the HPA axis response have been observed in CRHR1 knockout mice exposed to restraint, social defeat or forced swim stress [20, 22] but only minor alterations in the CRHR2 knockout mice [20, 23] . The lack of CRHR1 also protects against stress-induced hypophagia [24] . Consistent with this, delivery of a non-specific CRH antagonist into the third [25], but not in the lateral or the fourth ventricle [25, 26] prevents the weight loss induced by stress, implicating the hypothalamus as the likely target for this effect. Indeed, this lends support to the hypothesis that the effects of stress on weight loss involve CRH release within the PVN and the inhibition of NPY-neurons [27] . However, infusions of CRHR2 antagonists in the bed nucleus of the stria terminalis (BNST) and lateral septum (LS) [28] or CRHR1 antagonists to the basolateral amygdala (BLA) [29] can also prevent stress-induced anorexia. It should be noted, however, that these beneficial effects of the CRH antagonists are rather mild and short lived in the stress condition [30] ; most studies report effects at 1-hour post stress in food-deprived rats [31, 32] . Future studies should aim to follow the effects of these CRH receptor antagonist drugs for a longer period after the stress. Influence of prior chronic stress exposure on body weight change after an acute immobilization (IMO). Rats were exposed to 9 days of handling (control), chronic unpredictable stress (CUS) or chronic immobilization (IMOch). On day 10, half of the rats in each group were exposed to handling (non-stress condition; Control-NS, IMOch-NS and CUS-NS), or acutely exposed to 1 h of IMO (control-IMOa, IMOchIMOa and CUS-IMOa). Data are represented as means + S.E.M. (n = 6-9) of cumulative body weight changes, relative to the body weight achieved before the acute IMO exposure (day 10). Only the rats exposed to stress for the first time (Control-IMOa) lose weight after IMO ( p < 0.001 vs Control-NS group), while rats with either chronic IMO or CUS are protected from the body weight reduction induced by IMO. PS indicates the day post-stress (Pastor-Ciurana et al. 
Body weight reduction and energetic status
It is widely accepted that manipulations causing increased sympathetic tone (such as that induced by stress) are linked to increased thermogenesis in brown adipose tissue (BAT), decreased food intake and body weight [33] . Catecholamines stimulate lipolysis and the release of fatty acids from the adipose tissue, and also glycogenolysis and gluconeogenesis in the liver [34, 35] . CRH and ACTH contribute to stimulate the SNS and the noradrenaline release [36, 37] , and extrahypothalamic brain areas containing CRH immunoreactive neurons, like BNST and central amygdala, participate through the simulation of the locus coeruleus (LC) [38] . Energy expenditure increases while the respiratory quotient decreases during restraint or chronic mild stress [14, 39] . This increase in energy expenditure is coupled to an increase in body and BAT temperature under stress in rodents [36, 40, 41] , mediated by the glutamatergic stimulation of the dorsomedial hypothalamus to the rostral medullary raphe region (rMR) that participates in the sympathetic stimulation of BAT [40] . Stress-linked hyperthermia can be prevented with a receptor agonist of 5-HT 1A in the rMR, by CRH antagonists delivery to the brain ventricles [36] and also by antagonists to b-3 adrenoceptor highly expressed in BAT [40] [41] [42] . Indeed, stress hyperthermia seems to be mediated by BAT thermogenesis. Moreover, acute and chronic immobilization increase UCP-1 activity in BAT, and the effect is stronger after chronic stress [43] ; this fits with the increased response of BAT thermogenesis to norepinephrine after repeated stress [44] . On the other hand, GCs can oppose these effects; dexamethasone inhibits adrenergic stimulation of the functioning of human brown adipocytes [45] , and corticosterone attenuates the stimulatory effects of ACTH and norepinephrine on BAT (increase UCP1 expression) in vitro and in vivo in mice through the GR receptors [37] .
The catabolic effects of SNS activation during stress are not only observed in BAT but also in white adipose tissue (WAT). In WAT, the release of catecholamines under stress and the consequent stimulation of b adrenergic receptors increases lipolysis and inhibits the proliferation of preadipocytes [46] , while the lack of norepinephrine increases the fat cell number and the WAT mass [47] . In addition, repeated immobilization stimulates catecholamine biosynthesis in visceral WAT [48] , and chronic cold stress [49 ] or in vitro culture with ACTH [37] can change the WAT to BAT-like morphology, with high expression levels of UCP-1 perhaps increasing thermogenesis.
Chronic stress increases body weight and risk for cardiometabolic disease
Whereas in rodents stress usually induces weight loss, in humans, this effect is not always observed, and depends upon which experimental designs are used to explore the stressor. In rodents, the classic stressors like restraint, or forced swim induce very strong stress responses, and it is possible that these rodent stressors are modeling a severely traumatic situation. In addition, when these stressors are repeatedly presented, rodents adapt very fast [50] . Human studies typically involve milder but chronic stressors [3] , and they demonstrate that stress can increase body weight and preference for palatable food in many ways [9, 10, 51, 52] . Stress engages pathways that confer the reward value of foods, such as the mesocorticolimbic dopamine pathway. By activating this pathway, glucocorticoids increase motivating aspects of drugs [53] , and potentially also for palatable food. In this regard, the 'Comfort Food' hypothesis proposed by Dallman [54] suggests that eating palatable high fat/sugar food can relieve negative emotions linked to stress and reduce the HPA axis response [52, 54, 55] . Firstly, it was suggested that the visceral fat might act as a signal of energy stores that feeds back to inhibit the HPA axis [54, 56 ], but this hypothesis has been updated. Using a model of limited access to sucrose, which reduces the stress response, Ulrich-Lai et al. [57 ] propose that sucrose intake alters signaling between the PVN and the basolateral/ medial amygdala on one side and the BNST on the other, resulting in a diminished response to stress.
Apart from increasing the motivation to eat palatable food, increasing visceral obesity is one way in which chronic stress increases the risk of metabolic syndrome, since abdominal obesity is one of its core symptoms (together with hypertension, high fasting glucose levels and triglycerides and low HDL cholesterol levels), metabolic alterations strongly related with the development of type-2 diabetes and cardiovascular disease [58] .
Acute and chronic effects of glucocorticoids Glucocorticoids (GC) have a complex role in energy balance and metabolic control. Acutely, they are considered catabolic hormones, that increase lipolysis and the release of fatty acids from WAT [59] , and stimulate hepatic glycogenolysis and gluconeogenesis, increasing the circulating glucose concentrations and the glycogen deposition [60] . However, an anabolic effect of GCs within WAT has been demonstrated [61 ] . People suffering from Cushing syndrome, endogenous hypercortisolism, have abdominal obesity, increased body fat, high blood pressure, insulin resistance and preference for fat food [62, 63] . It has been hypothesized that insulin, frequently released as a consequence of GC action [64] [65] [66] , might be crucial in food choice and fat accumulation in stress [67] . In absence of insulin, GC increase the intake of chow, rich in carbohydrates [65] , while in presence of insulin, GC increase the preference for more palatable options [68, 69] . However, when the GC levels are constantly high as is the case of chronic stress, insulin resistance is observed. Thus, other factors have to be responsible for the fat preference in the long term.
Glucocorticoids also affect BAT, which is involved in thermoregulation and energy expenditure. BAT-induced thermogenesis can contribute to a reduction in body fat [70] . GCs appear to be required for BAT cell differentiation (in vitro) [45, 71] yet in high concentrations, glucocorticoids have been shown to impair BAT-induced thermogenesis in vivo [72] . Consistent with this, GCs inhibits the adrenergic stimulation of the functioning of the brown adipocytes in vitro [45, 71] . Therefore, GCs may impact on energy balance through their actions in WAT and BAT. However, under stressful situations, other factors like the activation of the SNS can oppose these effects, and the net result can depend on the combination of both systems.
Neuropeptide Y is engaged in the stress response at many levels Another important peptide linking stress and adiposity is neuropeptide Y (NPY), a peptide produced both in the arcuate nucleus (ARC) of the hypothalamus and in neurons of the SNS, from where it is released as an adrenergic cotransmitter under some stress situations [73] . Centrally, NPY potently increases food intake through its effects in the hypothalamus, that can be considered a fight against starvation under stress. Additionally, central NPY exerts protective effects under stress by reducing anxiety and depressive-like behaviors [74] and can increase fat intake when is infused in the Nucleus Accumbens [75] . Simultaneously, injections of a synthetic GC or one session of footshock increase NPY content in the ARC, and decrease the amount of CRH in the mediobasal hypothalamus [64, 76] , both of which could contribute to a feeding response. Likewise, chronic restraint increases the expression of the orexigenic peptide agouti-related peptide (AgRP, which colocalises with NPY) in the lateral hypothalamus and down-regulates the melanocortin receptor 4 (MC4) in ARC, that responds to the anorexigenic proopiomelanocortin (POMC) [77] , potentiating orexigenic systems. However, a parallel stimulation of anorexigenic pathways has been also observed in the ARC, since acute footshock or restraint down-regulates AgRP [76, 77] , and acute restraint increases the expression of POMC in the whole hypothalamus [78] .
NPY can be released as an adrenergic cotransmitter, acting by itself or modulating the effects of norepinephrine and ATP, also released from the sympathetic terminals. For example, in WAT, NPY appears to oppose the effects of norepinephrine, inhibiting lipolysis induced by a b-agonist in cultured adipocytes [79] . Kuo et al.
[49 ] demonstrated that NPY is upregulated in WAT after chronic cold and social defeat stress in mice fed the high fat-high sucrose diet. Besides, the increase in abdominal fat and the symptoms resembling metabolic syndrome in these mice were reversed by delivery of a NPY2R antagonist to the abdominal fat. They show that NPY increases under stress, and stimulates angiogenesis and adipogenesis through NPY2R. Moreover, when sympathetic neural cells are treated with dexamethasone, the NPY expression is remarkedly increased [49 ] , and could be one of the mechanisms explaining some of the obesogenic effects of GCs.
Conclusions: is stress altering energy balance?
It seems evident that stress can impact on energy balance in many diverse ways and at different levels ( Figure 2 ). Stress can trigger both orexigenic-like and anorexigeniclike responses reflecting a variety of intrinsic and external factors such as individual differences, (palatable) food availability and/or the type of stress. Chronic and acute stressors recruit some overlapping but also divergent systems relevant for metabolic control. From an evolutionary perspective, it seems reasonable that chronic stressors promote the activation of pro-obesogenic mechanisms that favor the accumulation of central/visceral fat. This is because constant activation of the stress response can be interpreted as living in a constant unsafe situation, for which it is beneficial to store central (easy to use) fat and glycogen in the liver and hence, help supply the brain with energy on short demand. This apparently simple idea is difficult to demonstrate experimentally in rodents, probably because classical stressors do not mimic the human situations and it is difficult to find direct comparisons between acute and chronic stress. Most rodent stress models that increase adiposity like social crowding [80] social defeat [49 ,81] or cold stress [49 ] seem to potently stimulate NPY secretion, that could be an important factor in future studies that attempt to model the metabolic alterations seen in humans. Future experiments aimed to directly compare the acute and chronic effects of these stressors on the HPA and SNS interactions regarding energy balance are needed. It is imperative to know whether differences in the adaptations of the anorexigenic and orexigenic responses along chronic stress can explain the final impact on metabolism. Ultimately, an increased understanding of the links between different types of stress with food intake and energy balance will facilitate the development of strategies that circumvent the development of stress-linked metabolic disease.
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